Arm A: Gedatolisib + Palbociclib + Fulvestrant

Drug identity checked against registry records

Also recorded as PF-05212384, IBRANCE, Faslodex

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.